Key result
Cardiomyocyte-specific deletion of p38 MAPKα in mice subjected to pressure overload resulted in rapid left ventricular dilatation and impaired systolic function within 48 hours, driven by lipid accumulation and neutrophil infiltration.
Why the study?
Although p38 MAPKα is accepted to play a central role in the cardiac stress response, its function in maladaptive cardiac hypertrophy remained not unambiguously defined.
Does cardiomyocyte-specific p38 MAPKα knockout exacerbate cardiac dysfunction and inflammation in response to angiotensin II-induced pressure overload in mice?
Does cardiomyocyte-specific p38 MAPKα knockout exacerbate cardiac dysfunction and inflammation in response to angiotensin II-induced pressure overload in mice?
Answers are grounded in this paper and cite their sources.
Cardiomyocyte p38 MAPKα plays a crucial protective role in early adaptation to pressure overload by preventing metabolic dysfunction, lipid accumulation, and neutrophil-driven cardiac inflammation.
Although p38 MAP Kinase α (p38 MAPKα) is generally accepted to play a central role in the cardiac stress response, to date its function in maladaptive cardiac hypertrophy is still not unambiguously defined. To induce a pathological type of cardiac hypertrophy we infused angiotensin II (AngII) for 2 days via osmotic mini pumps in control and tamoxifen-inducible, cardiomyocyte (CM)-specific p38 MAPKα KO mice (iCMp38αKO) and assessed cardiac function by echocardiography, complemented by transcriptomic, histological, and immune cell analysis. AngII treatment after inactivation of p38 MAPKα in CM results in left ventricular (LV) dilatation within 48 h (EDV: BL: 83.8 ± 22.5 µl, 48 h AngII: 109.7 ± 14.6 µl) and an ectopic lipid deposition in cardiomyocytes, reflecting a metabolic dysfunction in pressure overload (PO). This was accompanied by a concerted downregulation of transcripts for oxidative phosphorylation, TCA cycle, and fatty acid metabolism. Cardiac inflammation involving neutrophils, macrophages, B- and T-cells was significantly enhanced. Inhibition of adipose tissue lipolysis by the small molecule inhibitor of adipocytetriglyceride lipase (ATGL) Atglistatin reduced cardiac lipid accumulation by 70% and neutrophil infiltration by 30% and went along with an improved cardiac function. Direct targeting of neutrophils by means of anti Ly6G-antibody administration in vivo led to a reduced LV dilation in iCMp38αKO mice and an improved systolic function (EF: 39.27 ± 14%). Thus, adipose tissue lipolysis and CM lipid accumulation augmented cardiac inflammation in iCMp38αKO mice. Neutrophils, in particular, triggered the rapid left ventricular dilatation. We provide the first evidence that p38 MAPKα acts as an essential switch in cardiac adaptation to PO by mitigating metabolic dysfunction and inflammation. Moreover, we identified a heart-adipose tissue-immune cell crosstalk, which might serve as new therapeutic target in cardiac pathologies.
No takes yet. Share an insight, caveat, or question.
Bottermann et al. (2022) studied Heart failure / Pressure overload hypertrophy. Cardiomyocyte-specific p38 MAPKα knockout vs. Control mice (p38flox/flox littermates) was evaluated on Left ventricular dilatation (End Diastolic Volume) and systolic function (Ejection Fraction) at 48 hours. Cardiomyocyte-specific deletion of p38 MAPKα in mice subjected to pressure overload resulted in rapid left ventricular dilatation and impaired systolic function within 48 hours, driven by lipid accumulation and neutrophil infiltration.
Synapse has enriched 10 related papers. Consider them for comparative context: